Skip to content

Comparison Between Different Filling Pressures in Diagnostic Outpatient Hysteroscopy

Comparison Between Different Filling Pressures in Diagnostic Outpatient Hysteroscopy: A Double Blinded Randomised Controlled Trial.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02142686
Enrollment
240
Registered
2014-05-20
Start date
2014-05-31
Completion date
2015-04-30
Last updated
2016-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hysteroscopy

Keywords

Hysteroscopy, Filling pressures

Brief summary

The aim of this study is to compare different filling pressures

Detailed description

This study is a prospective double blinded randomised controlled trial. 240 women will be randomly divided into 3 groups, each containing 70 women. Randomisation will be performed using a computer generated random numbers and sealed envelopes. Full history will be taken followed by general and local examination. The procedure will be done in the lithotomy position. Hysteroscopy will be done using a 5mm outer diameter continuous flow hysteroscope with a French working channel and a 30 degrees direction of view provided by Techno GmbH and CO. The hysteroscope will be introduced using the vaginoscopy technique, in which no speculum will be used. The cervix will be detected and the external os will be identified using the hysteroscope. The hysteroscope will be introduced in the uterine cavity. Saline will be used as the distension medium and the pressure will be set at 80mm Hg until the hysteroscope is introduced in the uterine cavity. After the hysteroscope is introduced into the uterine cavity, the filling pressure will remain at 80mm Hg in group1, will be reduced to 50mm Hg in group 2 and to 30mmHg in group 3. Randomisation will be double blind; neither the operator nor the patient will know the pressure during the procedure, a third party will set the pressure according to the computer generated random numbers. The anterior wall, posterior wall and tubal ostea will be visualised, any polyps, adhesions septa, congenital malformations or submucous fibroids will be noted.

Interventions

After the hysteroscope is introduced into the uterine cavity, the filling pressure will remain at 80mm Hg.

DEVICEFilling pressure 50

After the hysteroscope is introduced into the uterine cavity, the filling pressure will be reduced to 50mm Hg.

DEVICEFilling pressure 30

After the hysteroscope is introduced into the uterine cavity, the filling pressure will be reduced to 30mm

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Age 18-60 years * Has a clear Indication to have an outpatient hysteroscopy * Consent to participate in the study

Exclusion criteria

* Premenstrual and midmenstrual patients. * Patients with missed periods. * Patients with known cardiac disease. * Patients who need operative hysteroscopy

Design outcomes

Primary

MeasureTime frameDescription
adequate visualization of the uterine cavity10 minutes after starting the procedure.10 minutes after starting the procedure, the operator will document if adequate visualization was achieved using the allocated pressure. If visualization was not adequate, he will document that adequate visualization was not achieved using the allocated pressure and will ask for the pressure to be adjusted.

Secondary

MeasureTime frameDescription
Pain perceived by the patient10 minutes after starting the procedurePain will be assessed by a visual analogue scale 10 minutes after starting the procedure.
Pain perceived by the patient 30 minutes after starting the procedure.30 minutes after starting the procedure.Pain will be assessed by a visual analogue scale 30 minutes after starting the procedure.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026